|Bid||294.51 x 1100|
|Ask||295.60 x 1400|
|Day's range||292.73 - 300.05|
|52-week range||177.71 - 305.95|
|Beta (5Y monthly)||0.42|
|PE ratio (TTM)||24.18|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Has famed investor Cathie Wood lost her touch? Vertex Pharmaceuticals is close to hitting a new all-time high as the drugmaker's business is firing on all cylinders. During the second quarter, Vertex Pharmaceuticals' top line jumped by 22% year over year to $2.20 billion.
Vertex Pharmaceuticals Incorporated's ( NASDAQ:VRTX ) price-to-earnings (or "P/E") ratio of 24x might make it look like...
Most investors would like to see their stock portfolio grow significantly, especially if they have quite a few years left until retirement. Alphabet (NASDAQ: GOOG), Vertex Pharmaceuticals (NASDAQ: VRTX), Eli Lilly and Company (NYSE: LLY), and Meridian Bioscience (NASDAQ: VIVO) all show solid potential to grow your investments significantly. Alphabet's stock has risen 105% over the past five years.